Skip to main content Start main content
Prof Zheng interview screenshot

Prof. Zheng Zijian interviewed by the 21st Century Business Herald regarding flexible electronics

Prof. Zheng Zijian, Chair Professor of Soft Materials and Devices, Associate Director of the Research Institute for Intelligent Wearable Systems and Associate Director of the University Research Facility in Materials Characterisation and Device Fabrication, was interviewed by 21st Century Business Herald on his research on flexible electronics as well as the pros and cons of university-nurtured startups and the I&T ecosystem in Hong Kong. Prof. Zheng highlighted the vast potential of flexible electronics in smart wearables, healthcare, sports monitoring, and robotics during the interview. This technology, enabling bendable and stretchable devices through advanced fabrication techniques, is reshaping electronic product applications across industries. Reflecting on Hong Kong's evolving innovation and technology landscape, Prof. Zheng noted the significant improvements over the past years, emphasizing enhanced opportunities for innovation and entrepreneurship. Stay tuned for more insightful discussions and groundbreaking discoveries in the realm of flexible electronics and technological advancements, as Professor Zheng continues to drive innovation and inspire the next generation of tech enthusiasts in Hong Kong and beyond. Online coverage: 21st Century Business Herald “港”创科25人|专访香港理工大学讲座教授郑子剑:香港科研水平全球领先,柔性电子应用前景广阔 Mobile|Desktop|LinkedIn|Weibo 3 September 2024  

10 Sep, 2024

News

Dr Ma_photo

Dr Ma Cong Pioneering Research Revolutionizing Antibiotics to Combat Superbugs

A research team led by Dr. Ma Cong, Associate Professor of the Department of Applied Biology and Chemical Technology and the co-founder of a PolyU startup YnnoMed Limited, is on the verge of a breakthrough in developing new drugs to combat superbugs. The team, which has identified 1,000 bioactive molecules that could potentially develop into new antibiotics to combat drug-resistant bacteria, has won multiple local and international awards for their groundbreaking work.   The team has identified five chemical components proven effective in killing all known superbugs in laboratory and animal experiments. Although much of the work has been done in Hong Kong, clinical trials on humans will commence in mainland China in 2026, with the team aspiring to establish clinical research collaborations in the United States as well.   Currently, before a drug can be utilized in Hong Kong, it must already be registered in at least two of the 36 countries specified by the Department of Health, a list that includes the US and China. As we await the establishment of the Hong Kong Centre for Medical Products Regulation, we wish Dr. Ma and his team success in their endeavors and hope that the new drug can be swiftly introduced and made available in the market.   Online coverage: SCMP - https://polyu.me/3YWExND (subscription required)

10 Sep, 2024

News

Student Shangjin Award

ABCT Postgraduate Student Miss Jin Shang Wins Two Best Poster Awards

Our ABCT postgraduate student Miss Jin Shang under the supervision of Dr. Zhao Qian has garnered significant accolades for her research efforts. Her exceptional work in the field of pharmaceuticals and antiviral therapeutics has been recognized at two esteemed symposiums, where she emerged victorious with the Best Poster Awards. At the 18th Chinese International Peptide Symposium (CPS 2024) held in July 2024, Miss Jin Shang's presentation on "Deconvoluting the Controversial Antiviral Activity of Hydroxychloroquine through Target Identification with Chemical Proteomics" captivated the audience and earned her the distinguished Best Poster Award. Prior to this, Miss Jin Shang also triumphed at the Hong Kong - Jiangsu Symposium on Drug Discovery and Development in May 2024, where her research on the same topic was lauded with the Best Poster Award. Her work delves deep into unraveling the mysteries surrounding the antiviral properties of Hydroxychloroquine using cutting-edge techniques in chemical proteomics. These accolades are a testament to Miss Jin Shang's unwavering commitment to scientific excellence and her invaluable contributions to the field of pharmaceutical research. Her innovative approach and dedication to advancing knowledge in antiviral therapeutics have rightfully earned her these prestigious honors. Congratulations to Miss Jin Shang on this remarkable achievement. Her success not only reflects her individual brilliance but also highlights the outstanding research being conducted at Dr. Zhao Qian's esteemed research group.  

5 Sep, 2024

Awards

Website banner - Dr Zhao

Dr. Zhao Qian Recognized as 'Rising Star in Proteomics and Metabolomics 2024' by Journal of Proteome Research

We are delighted to announce that Dr. Zhao Qian, Associate Professor of the Department of Applied Biology and Chemical Technology, has been honored with the recognition of 'Rising Star in Proteomics and Metabolomics 2024' by the Journal of Proteome Research (JPR). This recognition highlights Dr. Zhao's exceptional contributions and dedication to the fields of proteomics and metabolomics. The 'Rising Stars in Proteomics and Metabolomics 2024' Collection is a prestigious acknowledgment of emerging scientists chosen by the Associate Editors of the Journal of Proteome Research and the Editorial Advisory Board members. Dr. Zhao is among the 34 authors included in this esteemed Collection, all of whom are early career researchers showcasing remarkable originality and potential for the advancement of proteomics and metabolomics. Please join us in congratulating Dr. Zhao on this well-deserved recognition. Her commitment to excellence and advancement in proteomics and metabolomics serve as an inspiration to us all. We eagerly anticipate the continued success and impactful research emanating from her esteemed research group.  

5 Sep, 2024

Awards

20240822Prof Zheng Zijian

Prof. Zheng Zijian's interview on RTHK's radio programme “Backchat”: PolyU's success in SVIIF 2024

Prof. Zheng Zijian, Chair Professor of Soft Materials and Devices, Associate Director of the Research Institute for Intelligent Wearable Systems and Associate Director of the University Research Facility in Materials Characterisation and Device Fabrication, was interviewed by RTHK’s radio programme “Backchat” on 22 August on PolyU’s success in the Silicon Valley International Inventions Festival 2024 (SVIIF) and his award-winning project “ICU-grade Wireless Breathable Cardiac Electronic Skin”. Online coverage: RTHK Backchat(48:22 - 54:17) 22 August 2024

26 Aug, 2024

News

66b677f8e4b05e123809bda1

Two PolyU projects secure support from Taihu Lake Talent Plan

The 2024 Taihu Talent Development Conference, themed "New Era, New Talents, New Ecosystem," commenced in Wuxi, Jiangsu, on 9 August 2024. The Hong Kong government's "Research, Academic and Industry Sectors One plus Scheme" saw its first batch of six project teams receive funding under the "Taihu Lake Talent Plan." These projects will benefit from a range of favourable policies including priority investment and talent incentives in Wuxi, facilitating their rapid implementation and growth.   Among the distinguished projects, the "Laire Tech" project led by Prof. Wang Zuankai, Associate Vice President (Research and Innovation), and the "Composite Current Collectors" project led by Prof. Zheng Zijian, Chair Professor of Soft Materials and Devices, Associate Director of the Research Institute for Intelligent Wearable Systems and Associate Director of the University Research Facility in Materials Characterisation and Device Fabrication, secured funding and other support from the Taihu Lake Talent Plan.   The Taihu Lake Talent Plan, initiated in 2016, aims to attract and utilize talents from various sectors. Wuxi authorities revealed that the six Hong Kong project teams receiving special support under this plan are represented by the primary subsidiary of Wuxi Guolian Group in Hong Kong and the operating entity of the Wuxi Hong Kong Science and Innovation Center, Surrich International. These teams collaborated with Hong Kong universities and successfully obtained funding after rigorous evaluation by the Hong Kong government, becoming the inaugural beneficiaries of the Hong Kong "Research, Academic and Industry Sectors One plus Scheme." These projects and their esteemed professorial teams have high expectations placed upon them, with the Hong Kong government committing over HK$200 million in initial support.   Congratulations to our PolyU project teams for their achievements and recognition in this groundbreaking endeavour!   Online coverage: Ta Kung Pao - https://polyu.me/3M05Df1 Wen Wei Po - https://polyu.me/3WVIfpj China Review News - https://polyu.me/46GNEnj

13 Aug, 2024

News

Weixin Image_20240812144226

PolyU and ChemPartner collaborate on the development of novel immunotherapy agents

The Hong Kong Polytechnic University (PolyU) has announced a formal collaboration with Shanghai ChemPartner Co., Ltd. to jointly develop next-generation cancer immunotherapy agents. This partnership combines expertise from both academia and industry, with the long-term goal of benefiting cancer patients. PolyU's novel targets will be further developed into antibody-based, personalized cancer treatments. The collaboration leverages the university's strengths in basic science research and the industry's commercialization expertise, creating a synergistic relationship. The partnership aims to bridge the gap from foundational research to therapeutic drug development, thereby accelerating the innovation and commercialization of groundbreaking cancer treatments. This synergy not only fosters the exchange of knowledge and resources but also paves the way for significant advancements in oncology.   The signing of Memorandum of Understanding (MOU) was held on 9 August 2024 to establish the partnership. The MOU was signed by Prof. Larry Ming Cheung CHOW, Head of the Department of Applied Biology and Chemical Technology at PolyU, and Mr. Shixin FAN, Board Director of Shanghai ChemPartner Co. Ltd.   Prof. Larry Ming Cheung Chow expressed his excitement about the collaboration, stating, "This partnership exemplifies the need for academia and industry to work closely together to achieve success. To create a win-win situation, we will focus on the early discovery phase of markers, while ChemPartner will work on the later stages of antibody development."   Mr. William Woo, Chairman and CEO of ChemPartner, emphasized the significance of this collaboration, saying, "Our cooperation with the Hong Kong Polytechnic University is a major event for ChemPartner. We hope that through this partnership, we can promote exchanges and collaboration between the two sides in the field of medical technology, share resources, complement each other's strengths, and jointly make greater contributions to human health."   理大與睿智醫藥合作開發新一代癌症免疫療法 香港理工大學 (理大) 宣佈與上海睿智醫藥有限公司(睿智醫藥)正式建立合作關係,共同開發新一代癌症免疫療法藥物。此次合作將結合學術界和醫藥業界的專業知識,以造福癌症患者為長期目標。理大發現的新靶點將得到進一步開發成基於抗體的個性化癌症治療藥物。大學基礎科學研究能力與業界商業化專業知識的結合是完美的合作方式。雙方合作將充分利用各自的優勢資源,從基礎研究到治療性藥物開發,實現無縫過渡,加速創新癌症治療方法的研發和市場推廣。這不僅促進了知識和資源的共用,還為癌症治療的創新和突破創造了有利條件。   雙方於2024年8月9日簽署合作諒解備忘錄,建立合作關係。備忘錄由理大應用生物和化學科技學系系主任周銘祥教授和上海睿智醫藥有限公司董事樊世新先生代表簽署。   周銘祥教授表示:"理大與睿智醫藥的合作是一個非常激動人心的時刻。這次合作體現了學術界和業界需要更緊密地合作才能取得成功。為了實現雙贏,我們將專注於標記物的早期發現階段,而睿智醫藥將致力於抗體開發的後期階段。"   睿智醫藥董事長兼首席執行官胡瑞連先生表示:"與香港理工大學的合作是睿智醫藥發展史上的一件大事,我們期待通過這次合作,能夠促進雙方在醫藥科技領域的交流與合作,實現資源分享,優勢互補,共同為人類的健康事業做出更大的貢獻。"   PolyU and ChemPartner signed a MOU on 9 August 2024 to establish a formal collaboration. The MOU was signed by Prof. Larry Ming Cheung Chow (3rd from right) and Mr. Shixin Fan, Board Director of ChemPartner (3rd from left). Other guests joining the ceremony included Mr. William Woo, Chairman and CEO of ChemPartner (2nd from left), Mr. Yinqun Zha, CFO of ChemPartner (1st from left), Prof. Yanxiang Zhao, Associate Head and Professor of Department of Applied Biology and Chemical Technology at PolyU (2nd from right) and Prof. Thomas Leung, Professor at Department of Applied Biology and Chemical Technology at PolyU (1st from right). 理大與睿智醫藥於2024年8月9日簽署合作諒解備忘錄,由理大應用生物和化學科技學系系主任周銘祥教授(右三)和上海睿智醫藥有限公司董事樊世新先生(左三)代表簽署。其他出席嘉賓包括睿智醫藥董事長兼首席執行官胡瑞連先生、睿智醫藥首席財務官查胤群先生、理大應用生物和化學科技學系副系主任趙燕湘教授及理大應用生物及化學科技學系梁潤松教授。   The Hong Kong Polytechnic University (PolyU) PolyU is committed to the development of biopharmaceuticals in Hong Kong. It has developed the first undergraduate degree in biotechnology (Bachelor of Science (Honours) in Applied Biology with Biotechnology) and the first Master degree in Biopharmaceutical Development and Commercialization in Hong Kong. The State Key Laboratory of Chemical Biology and Drug Discovery and other life sciences departments in PolyU have worked on the development of various anticancer drug and clinical devices. For more information, please visit: www.polyu.edu.hk   香港理工大學(理大) 理大致力發展香港生物製藥。 它在香港開設了第一個生物技術本科學位(應用生物兼生物科技(榮譽)理學士學位)和生物醫藥研發及產業化理學碩士。 理大化學生物學與藥物發現國家重點實驗室及其他生命科學部門致力於多種抗癌藥物和臨床設備的開發。  

13 Aug, 2024

News

SVIIF_Photo 1

PolyU Researchers Win Big at the Silicon Valley International Inventions Festival 2024

The Hong Kong Polytechnic University (PolyU) is proud to announce that its research teams and startups have achieved exceptional success at the 2024 Silicon Valley International Inventions Festival (SVIIF), held from July 26-28 in Santa Clara, California.   This global event, the largest of its kind in the United States, drew participation from approximately 30 countries and regions, representing a diverse array of academic institutions, research centers, and enterprises. Supported and attended by leading multinational corporations, investors, and entrepreneurs, the SVIIF serves as a crucial platform for inventors and the business community to explore commercialization opportunities and forge new partnerships.   Led by Prof. Christopher CHAO, PolyU Vice President (Research and Innovation), the PolyU research teams and startups showcased their innovations on the international stage, connecting with investors and business partners worldwide to raise the University’s global profile.   This year, PolyU research teams garnered nine prestigious awards at the SVIIF, including a semi-grand prize, two special prizes, five gold medals and one silver medal. The award-winning PolyU research projects spanned a diverse range of fields, including healthcare devices, advanced materials, artificial intelligence of things (AIoT), and sensing technology. These innovations exemplify PolyU's commitment to driving progress and addressing global challenges through cutting-edge research and entrepreneurship.   Notably, the project "ICU-grade Wireless Breathable Cardiac Electronic Skin" led by Prof. ZHENG Zijian, Chair Professor of Soft Materials and Devices, was awarded a Semi-grand Prize and a Gold Medal. This groundbreaking invention provides a seamless, continuous, comfortable, non-invasive, and inflammation-free electrocardiogram monitoring solution with ICU-grade accuracy, without the need for traditional wired and bulky clinical devices.   Additionally, Prof. ZHAO Xin, Professor at the Department of Applied Biology and Chemical Technology and Founder of ReNew Biotechnology Limited, won the Silver Medal of the Croatian Union of Innovators for her project "3D Printed Triply Periodic Minimal Surface Bone Scaffolds."   Moreover, a collaborative project titled "MicroFish: A Lab-on-a-chip for On-site Detection of Microbial Contamination and Pollutants," led by Dr. CHUA Song Lin, Assistant Professor at the Department of Applied Biology and Chemical Technology and Co-founder of Microfish Limited, Dr. LIU Yang Sylvia, GBA Startup Postdoctoral Fellow at the Department of Applied Biology and Chemical Technology and Co-founder of Microfish Limited, and Dr. KHOO Bee Luan, Assistant Professor at the Department of Biomedical Engineering, City University of Hong Kong, was awarded a coveted Gold Medal.   We invite you to learn more about these groundbreaking PolyU projects by visiting the Appendix or the website of the PolyU Knowledge Transfer and Entrepreneurship Office.   PolyU's outstanding performance at the 2024 Silicon Valley International Inventions Festival is a testament to the university's commitment to innovation, entrepreneurship, and global impact. We congratulate our talented researchers and innovators on their remarkable achievements, which have once again positioned PolyU as a leading hub of cutting-edge research and technological breakthroughs.   Project Description Principal Investigator(s) Award(s) ICU-grade Wireless Breathable Cardiac Electronic Skin   This innovation offers a seamless and non-invasive electrocardiogram experience. It ensures continuous, comfortable and inflammation-free heart monitoring with accuracy as high as achieved in intensive care units (ICU), but without traditional wired and bulky clinical devices. It has been adopted for early detection of heart disease in daily life and in outpatient clinics, while also being suitable for monitoring ICU patients both during and after surgery. The wearable cardiac electronic system is ultrathin and ultralightweight with a thickness of only 181 μm and weight of 0.489g. It is highly stretchable and permeable, and of a high-integration-density. It also allows realtime acquisition, analysis and wireless transmission of cardiac data via a smartphone. Prof. ZHENG Zijian Chair Professor of Soft Materials and Devices, Department of Applied Biology and Chemical Technology of PolyU; Associate Director, Research Institute for Intelligent Wearable Systems, and University Research Facility in Materials Characterisation and Device Fabrication   Semi-Grand Prize Gold Medal   3D Printed Triply Periodic Minimal Surface Bone Scaffolds   The 3D-printed triply periodic minimal surface (TPMS) bone scaffolds use β-tricalcium phosphate with a hyperboloidal shape that mimics trabecular bone. The scaffolds are highly porous and interconnected, which helps reduce stress and increases their strength. They can support the adhesion and proliferation of human mesenchymal stem cells and promote the transformation of these cells into bone cells to support the formation of blood vessels, a process known as “osteogenesis-angiogenesis coupling”. This is achieved by the shape of scaffold which reorganises the cell’s internal structure, with focal adhesion kinase and mitogen activated protein kinase pathway activation. In-vivo evaluation demonstrates that TPMS scaffolds boost new bone formation and blood vessel growth. The scaffolds guide the development of bone and blood vessel cells using only their physical properties and demonstrate substantial improvements in bone regeneration without any additional substances. They pave the way towards a simple, safe, efficient and personalised bone graft solution with very significant potential for clinical use. Prof. ZHAO Xin Professor, Department of Applied Biology and Chemical Technology of PolyU; Founder, ReNew Biotechnology Limited (a PolyU academic-led startup) Prize of the Croatian Union of Innovators   Silver Medal MicroFish: A Lab-on-a-chip for On-site Detection of Microbial Contamination and Pollutants MicroFish is a palm-sized lab-on-a-chip device that can detect microbial pathogens and environmental pollutants. It is easy to operate by injecting samples into the lab-on-a-chip, which contains colorimetric chemical sensors, and then analyzing the positive or negative result. It allows for rapid, low-cost on-site monitoring of potential microbial outbreaks in aquacultures and livestock farms with limited access to diagnostic laboratories. The result is early detection of microbial pathogens or pollutants, enabling prompt responses to potential outbreaks of disease or environmental pollution. This innovation will reduce livestock mortality, thereby helping to prevent serious economic losses and will contribute to food security. This project supports UN Sustainable Development Goals, including Life Below Water, and Clean Water and Sanitation. Dr CHUA Song Lin Assistant Professor, Department of Applied Biology and Chemical Technology of PolyU; Co-founder, Microfish Limited (a PolyU academic-led startup)   Dr LIU Yang Sylvia GBA Startup Postdoctoral Fellow, Department of Applied Biology and Chemical Technology of PolyU; Co-founder, Microfish Limited (a PolyU academic-led startup)   Dr KHOO Bee Luan Assistant Professor, Department of Biomedical Engineering, City University of Hong Kong Gold Medal  

7 Aug, 2024

Awards

20240730Prof Zheng Zijian

Interview with Prof. Zheng Zijian on i-Cable’s "InnoAction" Programme

Prof. Zheng Zijian , Chair Professor of Soft Materials and Devices, Associate Director of the Research Institute for Intelligent Wearable Systems, Associate Director of the University Research Facility in Materials Characterization and Device Fabrication and Founding Member of the Hong Kong Young Academy of Sciences, was interviewed by i-Cable’s programme “InnoAction” on the positive impacts of the “Research, Academic and Industry Sectors One plus Scheme” on young scientists as well as his research projects on soft electronics. Online coverage: i-Cable 智·創未來 (00:10 - 12:33) 27 July 2024  

31 Jul, 2024

News

Website Banner rev

Faculty Awards for Outstanding Achievement 2024

Congratulations to the recipients of Faculty Awards for Outstanding Achievement 2024 in recognition of their outstanding performance in respect of teaching, research & scholarly activities and knowledge transfer. The award recipients are as follows:   Individual Awards Category Awardees Research and Scholarly Activities: Outstanding Researcher Prof. YAO Zhongping, Professor Teaching: Outstanding Teacher Dr LAM Kim Hung, Lecturer Knowledge Transfer: Industry Dr MA Cong, Associate Professor Knowledge Transfer: Society Dr CHUA Songlin, Assistant Professor   Congratulations to all the awardees for their remarkable accomplishment.

31 Jul, 2024

Awards

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here